Nitazoxanide
NDC 70954-934, Nitazoxanide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-934
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214844
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-934 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NITAZOXANIDE500 mg/1
Pharmacologic classes
Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-934-10 | 70954093410 | 6 TABLET in 1 BOTTLE (70954-934-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cd3652fa-a183-4fb6-9a21-73fbeba6fc4bNADAC price for package 70954093410
GET /v1/drugs/nadac/70954093410
Use it
Look up 70954-934 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-934 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-934. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.